EUVIMEDEUVIMED entdecken
Open Access

Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation

Narges Cheshmazar iD, Maryam Hamzeh-Mivehroud iD, Salar Hemmati iD, Hoda Abolhasani iD, Fatemeh Heidari iD, Hojjatollah Nozad Charoudeh iD, Matthes Zessin, Mike Schutkowski iD, Wolfgang Sippl iD, Siavoush Dastmalchi iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2023-0122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Narges Cheshmazar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Benzamides, Drug Design, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Biotechnology Research Center, Tabriz University of Medical Sciences, Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase InhibitorsBenzamidesDrug DesignCell ProliferationAntineoplastic AgentsHistone DeacetylasesDrug Screening Assays, AntitumorHumansStructure-Activity RelationshipMolecular StructureCell Line, TumorMolecular Docking Simulation

Stichwörter der Autor:innen

QSARbreast cancerhistone deacetylase inhibitorsmolecular dockingmolecular dynamics simulationstructure modificationsynthesis

Substanzen

Histone Deacetylase InhibitorsBenzamidesAntineoplastic AgentsHistone Deacetylasesbenzamide

Autor:innen und Institutionen

  • Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran.
  • Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 5166414766, Iran.
  • Drug applied research Center, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran.
  • Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Department of Pharmacology, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
  • Anatomical Sciences Department, Faculty of Medicine, Tabriz University of Medical, Tabriz, 5166614766, Iran.

ORCID-Profile: Narges Cheshmazar, Maryam Hamzeh-Mivehroud, Salar Hemmati, Hoda Abolhasani, Fatemeh Heidari, Hojjatollah Nozad Charoudeh, Mike Schutkowski, Wolfgang Sippl, Siavoush Dastmalchi

Förderung

  • Biotechnology Research Center, Tabriz University of Medical Sciences
  • Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences

Zitieren

APA

Cheshmazar, N., Hamzeh-Mivehroud, M., Hemmati, S., Abolhasani, H., Heidari, F., Charoudeh, H. N., Zessin, M., Schutkowski, M., Sippl, W., & Dastmalchi, S. (2024). Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0122

Vancouver

Cheshmazar N, Hamzeh-Mivehroud M, Hemmati S, Abolhasani H, Heidari F, Charoudeh HN, et al. Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0122

BibTeX
@article{Cheshmazar2024,
  author = {Cheshmazar, Narges and Hamzeh-Mivehroud, Maryam and Hemmati, Salar and Abolhasani, Hoda and Heidari, Fatemeh and Charoudeh, Hojjatollah Nozad and Zessin, Matthes and Schutkowski, Mike and Sippl, Wolfgang and Dastmalchi, Siavoush},
  title = {Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2023-0122}
}
Kostenlos starten →